Published in Cancer Chemother Pharmacol on March 18, 2003
Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods (2006) 3.36
Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice. Front Oncol (2013) 0.99
Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice. World J Gastroenterol (2007) 0.97
Inhibitory effect of antisense vascular endothelial growth factor RNA on the profile of hepatocellular carcinoma cell line in vitro and in vivo. World J Gastroenterol (2006) 0.83
Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas. World J Gastroenterol (2005) 0.82
A novel decoy receptor fusion protein for FGF-2 potently inhibits tumour growth. Br J Cancer (2014) 0.82
Effect of Weikangning on gastric cancer cell growth and expression of vascular endothelial growth factor and its receptors KDR and Flt-1. World J Gastroenterol (2005) 0.77
Macromolecule extravasation-xenograft size matters: a systematic study using probe-based confocal laser endomicroscopy (pCLE). Mol Imaging Biol (2013) 0.75
Multianalyte tests for the early detection of cancer: speedbumps and barriers. Biomark Insights (2007) 0.75
Natural killer T cell sensitization during neonatal respiratory syncytial virus infection induces eosinophilic lung disease in re-infected adult mice. PLoS One (2017) 0.75
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology (2006) 4.81
BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet (2006) 3.79
Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet (2006) 3.27
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest (2007) 3.01
Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol (2007) 2.69
Vascular gene expression in nonneoplastic and malignant brain. Am J Pathol (2004) 1.71
Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res (2004) 1.68
External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment rounds. Oncologist (2011) 1.59
Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis. Crit Care Med (2004) 1.57
Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption. Clin Cancer Res (2003) 1.50
Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions. J Clin Oncol (2005) 1.44
Clinically competent peers and support for education: structures and practices that work. Crit Care Nurse (2008) 1.40
Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma. Clin Cancer Res (2008) 1.35
Antisense inhibition of survivin expression as a cancer therapeutic. Mol Cancer Ther (2011) 1.33
LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice. Cancer Chemother Pharmacol (2003) 1.29
Murine endothelial cell lines as models of tumor endothelial cells. Clin Cancer Res (2004) 1.27
Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells. Cancer Res (2003) 1.26
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine. Invest New Drugs (2014) 1.26
A cell-based immunocytochemical assay for monitoring kinase signaling pathways and drug efficacy. Anal Biochem (2005) 1.25
Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. Microvasc Res (2008) 1.22
BMP4 is dispensable for skeletogenesis and fracture-healing in the limb. J Bone Joint Surg Am (2008) 1.20
Identification of genes expressed in malignant cells that promote invasion. Cancer Res (2003) 1.20
FIRE (Facilitating Implementation of Research Evidence): a study protocol. Implement Sci (2012) 1.18
Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int J Oncol (2009) 1.17
Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancy. Cancer Res (2005) 1.16
Cecal ligation and puncture with total parenteral nutrition: a clinically relevant model of the metabolic, hormonal, and inflammatory dysfunction associated with critical illness. J Surg Res (2004) 1.13
High-resolution quantitative computed tomography demonstrating selective enhancement of medium-size collaterals by placental growth factor-1 in the mouse ischemic hindlimb. Circulation (2006) 1.13
TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence. PLoS One (2011) 1.08
BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol Endocrinol (2011) 1.08
Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function. Mol Cancer Ther (2006) 1.06
Netrin-4 regulates angiogenic responses and tumor cell growth. Exp Cell Res (2008) 1.05
Myofibroblasts enable invasion of endothelial cells into three-dimensional tumor cell clusters: a novel in vitro tumor model. Cancer Chemother Pharmacol (2003) 1.04
Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248. Mol Cancer Ther (2008) 1.03
Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor. Invest New Drugs (2013) 1.02
"Did the trial kill the intervention?" experiences from the development, implementation and evaluation of a complex intervention. BMC Med Res Methodol (2011) 0.99
After you: conversations between patients and healthcare professionals in planning for end of life care. BMC Palliat Care (2012) 0.97
A nurse-led interdisciplinary primary care approach to prevent disability among community-dwelling frail older people: a large-scale process evaluation. Int J Nurs Stud (2013) 0.95
Endosialin is expressed in high grade and advanced sarcomas: evidence from clinical specimens and preclinical modeling. Int J Oncol (2011) 0.94
The promise of antibody-drug conjugates. N Engl J Med (2012) 0.94
Overexpression of BMP3 in the developing skeleton alters endochondral bone formation resulting in spontaneous rib fractures. Dev Dyn (2009) 0.94
Expression and function of BMP3 during chick limb development. Dev Dyn (2008) 0.93
Endosialin expression in side populations in human sarcoma cell lines. Oncol Lett (2011) 0.92
Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model. Prostate (2007) 0.92
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer. Invest New Drugs (2014) 0.92
An in vitro tumor model: analysis of angiogenic factor expression after chemotherapy. Cancer Res (2002) 0.91
Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia. Int J Oncol (2012) 0.91
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution. Int J Oncol (2008) 0.90
Innovating information-delivery for potential clinical trials participants. What do patients want from multi-media resources? Patient Educ Couns (2012) 0.90
Periosteal BMP2 activity drives bone graft healing. Bone (2012) 0.89
TGF-beta in cancer and as a therapeutic target. Biochem Pharmacol (2006) 0.89
Castration triggers growth of previously static androgen-independent lesions in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Prostate (2005) 0.89
Effects of hyperglycemia and insulin therapy on outcome in a hyperglycemic septic model of critical illness. J Trauma (2006) 0.88
Placental growth factor upregulation is a host response to antiangiogenic therapy. Clin Cancer Res (2011) 0.88
The effect of drought stress on heterozygosity-fitness correlations in pedunculate oak (Quercus robur). Ann Bot (2014) 0.88
Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence. Exp Cell Res (2009) 0.87
Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy. Microvasc Res (2011) 0.86
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008. Clin Cancer Res (2009) 0.86
Rehabilitation programme after stem cell transplantation: randomized controlled trial. J Adv Nurs (2010) 0.86
Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282. Mol Cancer Ther (2011) 0.86
Service user experiences of information delivery after a diagnosis of cancer: a qualitative study. Support Care Cancer (2007) 0.86
Electroacupuncture inhibits inflammation reaction by upregulating vasoactive intestinal Peptide in rats with adjuvant-induced arthritis. Evid Based Complement Alternat Med (2010) 0.86
Structures and practices enabling staff nurses to control their practice. West J Nurs Res (2008) 0.85
Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors. Mol Cancer Ther (2008) 0.85
BMPR-II is dispensable for formation of the limb skeleton. Genesis (2011) 0.84
Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer. Cancer Immun (2003) 0.83
Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs. Int J Oncol (2009) 0.83
Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair. J Orthop Res (2010) 0.83
A model of controlled acute hyperglycemia in rats: Effects of insulin and glucagon-like peptide-1 analog. J Pharmacol Exp Ther (2005) 0.82
Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents. Cancer Chemother Pharmacol (2009) 0.82
Report from the society for biological therapy and vascular biology faculty of the NCI workshop on angiogenesis monitoring. J Immunother (2004) 0.82
Genetic structure and seed-mediated dispersal rates of an endangered shrub in a fragmented landscape: a case study for Juniperus communis in northwestern Europe. BMC Genet (2011) 0.82
Evaluation of a project providing community palliative care support to nursing homes. Health Soc Care Community (1999) 0.81
Implementation of evidence-based practice in nursing using action research: a review. Worldviews Evid Based Nurs (2009) 0.81
Development of an asthma disease management program in a children's hospital. Curr Allergy Asthma Rep (2003) 0.80
Pericytes from human non-small cell lung carcinomas: an attractive target for anti-angiogenic therapy. Microvasc Res (2006) 0.80
Site-dependent angiogenic cytokine production in human tumor xenografts. Cytokine (2003) 0.80
Genz-644282, a novel non-camptothecin topoisomerase I inhibitor for cancer treatment. Clin Cancer Res (2011) 0.80
The chemosensitizing activity of inhibitors of glucosylceramide synthase is mediated primarily through modulation of P-gp function. Int J Oncol (2010) 0.80
Liminality as a framework for understanding the experience of cancer survivorship: a literature review. J Adv Nurs (2012) 0.80
Patient-reported auditory functions after stroke of the central auditory pathway. Stroke (2012) 0.79
Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugates. Cancer Chemother Pharmacol (2012) 0.79
Exploring patients' experience of receiving information about cancer: a comparison of interview and questionnaire methods of data collection. Health (London) (2010) 0.78
Human choriocarcinomas: placental growth factor-dependent preclinical tumor models. Int J Oncol (2011) 0.78
Role of nursing unit factors on performance of phlebotomy and subsequent blood culture contamination rates. J Nurs Care Qual (2010) 0.78
Nurse manager support: what is it? Structures and practices that promote it. Nurs Adm Q (2007) 0.78
Endosialin: a novel malignant cell therapeutic target for neuroblastoma. Int J Oncol (2011) 0.78
Hypoxia, tumor endothelium, and targets for therapy. Adv Exp Med Biol (2005) 0.78
[Effects of acupuncture on the number and degranulation ratio of mast cells and expression of tryptase in synovium of rats with adjuvant arthritis]. Zhong Xi Yi Jie He Xue Bao (2010) 0.78
Developments of Anticoagulants and New Agents with Anti-Coagulant Effects in Deep Vein Thrombosis. Mini Rev Med Chem (2017) 0.77
Preparation and application of attapulgite/iron oxide magnetic composites for the removal of U(VI) from aqueous solution. J Hazard Mater (2011) 0.77
Factors that influence mammography screening behaviour: a qualitative study of Greek women's experiences. Eur J Oncol Nurs (2012) 0.77
Comprehensive geriatric assessment for older women with early breast cancer - a systematic review of literature. World J Surg Oncol (2012) 0.77
Testing of the topoisomerase 1 inhibitor Genz-644282 by the pediatric preclinical testing program. Pediatr Blood Cancer (2011) 0.77